Related Experiment Video
Updated: May 18, 2026

The Intra-Aortic Balloon Pump
Published on: February 5, 2021
Prophylactic intra-aortic balloon pump in high-risk patients undergoing coronary artery bypass surgery: a
Michel Pompeu B O Sá1, Paulo E Ferraz, Rodrigo R Escobar
1Division of Cardiovascular Surgery of Pronto Socorro Cardiológico de Pernambuco - PROCAPE, Recife, Pernambuco, Brazil. michel_pompeu@yahoo.com.br
Insights
Prophylactic use of intra-aortic balloon pumps (IABP) significantly reduces hospital mortality and low cardiac output syndrome in high-risk patients undergoing coronary artery bypass graft surgery. This intervention also shortens intensive care unit and hospital stays.
Area of Science:
- Cardiovascular Surgery
- Critical Care Medicine
- Medical Device Technology
Background:
- Coronary artery bypass graft (CABG) surgery carries significant risks for high-risk patients.
- Prophylactic use of intra-aortic balloon pump (IABP) is a potential strategy to mitigate these risks.
- Evidence on the efficacy of prophylactic IABP in CABG is debated.
Purpose of the Study:
- To assess the efficacy of prophylactic intra-aortic balloon pump (IABP) in high-risk patients undergoing coronary artery bypass graft (CABG) surgery.
- To evaluate the impact of prophylactic IABP on hospital mortality, postoperative low cardiac output syndrome, and length of stay.
- To synthesize evidence from randomized controlled trials (RCTs) through meta-analysis.
Main Methods:
- Comprehensive literature search across multiple databases (MEDLINE, EMBASE, CENTRAL, etc.) and reference lists.
- Inclusion of only randomized controlled trials (RCTs) with duplicate assessment for eligibility, relevance, and data extraction.
- Meta-analysis performed using both fixed-effect and random-effect models to determine pooled relative risks and mean differences.
Main Results:
- Seven RCTs involving 345 patients (177 prophylactic IABP, 168 control) were included.
- Prophylactic IABP significantly reduced hospital mortality (RR 0.255, P<0.001) and postoperative low cardiac output syndrome (RR 0.206, P<0.001).
- Patients receiving prophylactic IABP experienced shorter intensive care unit and hospital stays (P<0.001), with minimal insertion site complications (7.4%) and no IABP-related deaths.
Conclusions:
- This meta-analysis provides strong evidence supporting the use of prophylactic intra-aortic balloon pump (IABP) in high-risk patients undergoing CABG.
- Prophylactic IABP is associated with significant reductions in hospital mortality and postoperative complications.
- The findings suggest that prophylactic IABP is a safe and effective strategy to improve outcomes in this patient population.
Objectives:
The aim of this study was to assess the efficacy of a prophylactic intra-aortic balloon pump (IABP) in high-risk patients undergoing coronary artery bypass graft surgery.
Methods:
MEDLINE, EMBASE, CENTRAL/CCTR, SciELO, LILACS, Google Scholar, and reference lists of relevant articles were searched. We included only randomized controlled trials. Assessments for eligibility, relevance, and study validity and data extraction were performed in duplicate using prespecified criteria. Meta-analysis was carried out using fixed-effect and random-effect models.
Results:
Seven publications fulfilled our eligibility criteria. There was no important statistical heterogeneity or publication bias among included studies. In total, 177 patients received prophylactic IABP and 168 did not. Overall relative risk (RR) for hospital mortality in patients treated with prophylactic IABP was 0.255 [95% confidence interval (CI), 0.122-0.533; P<0.001; same results for both effect models]. Pooled RR for postoperative low cardiac output syndrome was 0.206 (95% CI, 0.109-0.389; P<0.001) for the fixed-effect model and 0.219 (95% CI, 0.095-0.504; P<0.001) for the random-effect model. Patients treated with prophylactic IABP presented an overall difference in means for length of intensive care unit stay and hospital stay, which was lower than that in the control group (P<0.001 for both effect models). Only 7.4% (13/177) of patients who received prophylactic IABP developed complications at an insertion site, with no IABP-related death.
Conclusion:
This meta-analysis supports the use of prophylactic IABP in high-risk patients to reduce hospital mortality.
More Related Videos
05:25Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
Published on: September 15, 2023
07:39Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021